REQUEST A DEMO
Total
USD $0.00
Search more companies

Twi Pharmaceuticals, Inc. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Twi Pharmaceuticals, Inc. Profile Updated: December 05, 2023
Buy our report for this company USD 9.95 Available in: English & Chinese Download a sample report

TWi Pharmaceuticals, Inc. headquartered in Taipei, Taiwan, is an emerging specialty pharmaceutical company focusing on the development, manufacturing and commercialization of high barrier generic prescription products, and new drug products that will fulfill unmet medical needs.

Headquarters
4th Floor, No. 41, Lane 221, Gangqian Road, Neihu District
Taipei City; Taipei City;

Contact Details: Purchase the Twi Pharmaceuticals, Inc. report to view the information.

Website: http://www.twipharma.com

Basic Information
Total Employees:
Purchase the Twi Pharmaceuticals, Inc. report to view the information.
Outstanding Shares:
Purchase the Twi Pharmaceuticals, Inc. report to view the information.
Financial Auditors:
Purchase the Twi Pharmaceuticals, Inc. report to view the information.
Incorporation Date:
December 01, 1997
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
24.21%
Purchase this report to view the information.
23.64%
Purchase this report to view the information.
3.62%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
TWi Pharmaceutical Ltd.
100%
TWi Pharmaceuticals Europe Limited
100%
TWi Pharmaceuticals USA Inc.
100%
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
No results were found for this company.

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?